Sonja Molin

Sep 25, 2024 | via.ritzau.dk | Sonja Molin |Maria Concetta Fargnoli |Melinda Gooderham |Ana Giménez-Arnau

Del LEO Pharma will demonstrate true leadership in medical dermatology by presenting one of its largest ever scientific programs to date at this year’s EADV congress, with 5 late-breaking presentations and 23 scientific posters in total.(1-28) New late-breaking Anzupgo® (delgocitinib) cream data will include the full results of the Phase 3 head-to-head DELTA FORCE trial, as well as a wide range of associated clinical and real-world findings on delgocitinib cream and moderate to severe chronic...